Disease on EC 5.3.1.8 - mannose-6-phosphate isomerase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE 
TITLE OF PUBLICATION
LINK TO PUBMED
6-phosphofructokinase deficiency
[Exercise-induced muscular weakness, myalgia and contractures. I. A clinical review]
6-phosphofructokinase deficiency
[Exercise-induced muscular weakness, myalgia and contractures. II. Casuistic contribution]
Adenocarcinoma
Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma.
Alcohol Withdrawal Delirium
Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens.
Alcohol Withdrawal Delirium
[Activity of aldolase, aminotransferases, phosphohexoisomerase and ceruloplasmin in the course of delirium tremens]
Anemia
[Erythrocyte enzymes; activity of glycolytic enzymes of erythrocytes in anemia: phosphoglucomutase, phosphohexoisomerase, diphosphofructaldolase, lactic acid dehydrogenase.]
Biliary Tract Diseases
[Serum iron and copper levels and serum activity of phosphohexoisomerase and glutamic-pyruvic transaminase in patients with liver and biliary tract disease]
Blindness
Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.
Congenital Disorders of Glycosylation
A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
Congenital Disorders of Glycosylation
A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation.
Congenital Disorders of Glycosylation
Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib.
Congenital Disorders of Glycosylation
Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities.
Congenital Disorders of Glycosylation
Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
Congenital Disorders of Glycosylation
Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts.
Congenital Disorders of Glycosylation
Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
Congenital Disorders of Glycosylation
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose.
Congenital Disorders of Glycosylation
Ontogeny of D-mannose transport and metabolism in rat small intestine.
Congenital Disorders of Glycosylation
Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation.
Congenital Disorders of Glycosylation
Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose.
Congenital Disorders of Glycosylation
The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib.
Congenital Disorders of Glycosylation
[Carbohydrate-deficient glycoprotein syndrome (CDGS) type Ib. A hereditary metabolic disease and its therapy]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
A novel homozygous mutation in the mannose phosphate isomerase gene causing congenital disorder of glycation and hyperinsulinemic hypoglycemia in an infant.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Affinity capture and elution/electrospray ionization mass spectrometry assay of phosphomannomutase and phosphomannose isomerase for the multiplex analysis of congenital disorders of glycosylation types Ia and Ib.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Exogenous mannose does not raise steady state mannose-6-phosphate pools of normal or N-glycosylation-deficient human fibroblasts.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ontogeny of D-mannose transport and metabolism in rat small intestine.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
The metabolic origins of mannose in glycoproteins.
Coronary Artery Disease
Molecular and Biochemical Parameters Related to Plasma Mannose Levels in Coronary Artery Disease Among Nondiabetic Patients.
Cystic Fibrosis
Alginate biosynthetic enzymes in mucoid and nonmucoid Pseudomonas aeruginosa: overproduction of phosphomannose isomerase, phosphomannomutase, and GDP-mannose pyrophosphorylase by overexpression of the phosphomannose isomerase (pmi) gene.
Cystic Fibrosis
Functional analysis of the Burkholderia cenocepacia J2315 BceA(J) protein with phosphomannose isomerase and GDP-D: -mannose pyrophosphorylase activities.
Diphtheria
Assignment of hexosaminidase-B to chromosome 5, its segregation after diphtheria toxin selection, and the linkage of hexosaminidase-A, mannose phosphate isomerase, and pyruvate kinase (M2).
Ependymoma
[Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia]
Fructose Intolerance
Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.
Glioma
Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity.
Hepatitis
[The diagnostic value of determining serum iron and copper levels and activity of phosphohexoisomerase and pyruvic-glutamic transaminase in viral hepatitis]
Hepatitis A
[MICRODETERMINATION OF PHOSPHOHEXOISOMERASE (GLUCOSEPHOSPHATE ISOMERASE) IN THE SERUM AND THE CLINICAL IMPORTANCE OF ITS DETERMINATION IN INFECTIOUS HEPATITIS.]
Hypersensitivity
History of safe exposure and bioinformatic assessment of phosphomannose-isomerase (PMI) for allergenic risk.
Hypoglycemia
A novel homozygous mutation in the mannose phosphate isomerase gene causing congenital disorder of glycation and hyperinsulinemic hypoglycemia in an infant.
Hypoglycemia
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose.
Hypoglycemia
Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia.
Hypoglycemia
Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.
Hypoglycemia
Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome.
Leishmaniasis
Biochemical characterization of Leishmania (Viannia) braziliensis and Leishmania (Viannia) peruviana by isoenzyme electrophoresis.
Leishmaniasis
Use of FTA cards for direct sampling of patients' lesions in the ecological study of cutaneous leishmaniasis.
Leishmaniasis, Cutaneous
Nuclear and kinetoplast DNA analyses reveal genetically complex Leishmania strains with hybrid and mito-nuclear discordance in Peru.
Leukemia
Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia.
Liver Cirrhosis
Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans.
Liver Diseases
Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans.
Liver Diseases
Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice.
Liver Diseases
Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome.
Liver Diseases
[Studies on the serum enzymes in liver diseases; the activity of phosphohexoisomerase, aldolase and alkaline phosphatase.]
mannose-6-phosphate isomerase deficiency
A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.
mannose-6-phosphate isomerase deficiency
A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
mannose-6-phosphate isomerase deficiency
A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation.
mannose-6-phosphate isomerase deficiency
Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption.
mannose-6-phosphate isomerase deficiency
Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
mannose-6-phosphate isomerase deficiency
Clinical approach to inherited metabolic disorders in neonates: an overview.
mannose-6-phosphate isomerase deficiency
Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy.
mannose-6-phosphate isomerase deficiency
Clinical utility gene card for: Phosphomannose isomerase deficiency.
mannose-6-phosphate isomerase deficiency
Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency.
mannose-6-phosphate isomerase deficiency
Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).
mannose-6-phosphate isomerase deficiency
Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose.
mannose-6-phosphate isomerase deficiency
Mannose inhibition as a significant marker for differentiating among novobiocin-resistant staphylococci of relevance in clinical microbiology.
mannose-6-phosphate isomerase deficiency
Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency.
mannose-6-phosphate isomerase deficiency
Phosphomannose isomerase deficiency as a cause of congenital hepatic fibrosis and protein-losing enteropathy.
mannose-6-phosphate isomerase deficiency
Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation.
mannose-6-phosphate isomerase deficiency
Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome.
mannose-6-phosphate isomerase deficiency
Successful liver transplantation and long-term follow-up in a patient with MPI-CDG.
mannose-6-phosphate isomerase deficiency
The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib.
Muscular Diseases
[Glycogen myopathy with a probable deficiency of phosphohexoisomerase. Preliminary report]
Neoplasms
Mannose Impairs Lung Adenocarcinoma Growth and Enhances the Sensitivity of A549 Cells to Carboplatin.
Neoplasms
MPI-based bioinformatic analysis and co-inhibitory therapy with mannose for oral squamous cell carcinoma.
Neoplasms
[Clinical evaluation of the sedimentation reaction to cancer, indices of uropepsinogen and phosphohexoisomerase activity in the blood serum of patients with stomach cancer]
Neoplasms
[Histochemical demonstration of glial enzyme activity. II. Reagent and neoplastic glia]
Parasitic Diseases
Complexes of a Zn-metalloenzyme binding site with hydroxamate-containing ligands. A case for detailed benchmarkings of polarizable molecular mechanics/dynamics potentials when the experimental binding structure is unknown.
Protein-Losing Enteropathies
Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency.
Protein-Losing Enteropathies
Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia.
Protein-Losing Enteropathies
Phosphomannose isomerase deficiency as a cause of congenital hepatic fibrosis and protein-losing enteropathy.
Protein-Losing Enteropathies
Seizures and stupor during intravenous mannose therapy in a patient with CDG syndrome type 1b (MPI-CDG).
Protein-Losing Enteropathies
Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome.
Sarcoma
Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH).
Sinus Thrombosis, Intracranial
Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia.
Starvation
Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia.
Starvation
Sugar-Phosphate Metabolism Regulates Stationary-Phase Entry and Stalk Elongation in Caulobacter crescentus.
Stomach Neoplasms
[Clinical evaluation of the sedimentation reaction to cancer, indices of uropepsinogen and phosphohexoisomerase activity in the blood serum of patients with stomach cancer]
Stomach Neoplasms
[Effect of insulin on the activity of serum phosphohexoisomerase in gastric cancer]
Thrombocytopenia
Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities.
Thrombophilia
Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia.
html completed
